Human Mesenchymal Stem Cells from Dedifferentiated Fat: HMSC-DFAT

Human Mesenchymal Stem Cells from Dedifferentiated Fat (HMSC-DFAT) — frequently designated as HMSC-AD, DFAT cells, or dedifferentiated fat cells in the literature — are primary, multipotent human mesenchymal stem cell progenitors generated from mature adipocytes. The scientific field routinely navigates a nomenclature debate between “mesenchymal stem cells” and “mesenchymal stromal cells”; some international guidelines recommend “stromal cells” for heterogeneous primary isolates because uniform stemness criteria are not always met on a single-cell level.

Unlike a conventional adipose derived stem cell (ADSC) population isolated from the highly heterogeneous stromal vascular fraction (SVF), DFAT cells originate from a starting population of mature, lipid-laden fat cells isolated via a specialized ceiling culture method. During this process, a mature adipocyte appears to dedifferentiate by mechanisms that may include asymmetric division or direct phenotypic reversion; however, definitive single-cell lineage tracing in human cells is limited and these proposed routes are not universally proven. In culture, they revert to a primitive, proliferative, fibroblast-like morphology. While the initial cell-type isolation targets a uniform cell source, the resulting cultures can still exhibit functional variability depending on the starting status of the source cells and the specific induction environments. As primary progenitor cells, their population-doubling capacity is finite, and their proliferative kinetics and differentiation fidelity decline steadily with increasing passage numbers compared to immortalized cell lines or pluripotent stem cells.

While the dedifferentiation process occurs in vitro, the founding mature adipocytes are sourced directly from human fat tissue compartments, typically obtained from subcutaneous or visceral adipose tissue depots. While historically stem cell research focused heavily on isolating adult mesenchymal stem cells from human bone marrow, adipose tissue has become a highly valued tissue source due to its accessibility and abundance. By utilizing mature adipocytes as the source population, the DFAT method naturally minimizes much of the multi-lineage cellular contamination inherent to raw SVF or adipose stem cell isolations, which typically contain endothelial cells, pericytes, smooth muscle cells, and circulating hematopoietic stem cell lineages. However, investigators must still account for donor-specific variables; demographics such as age, body mass index (BMI), and the specific anatomical fat tissue depot used can introduce biological variations that require validation across multiple donor lots.

The primary biological function of HMSC-DFAT and related adipose stem cells in vivo is to maintain adipose homeostasis, but ex vivo, HMSC-DFAT demonstrate remarkable plasticity. Because they are derived from cells that have already completed one full cycle of lineage commitment, they can retain epigenetic marks reflecting their adipocyte origin. This epigenetic memory may bias adipogenic re-differentiation, though the exact degree and functional consequences vary by protocol and require further comparative study. Under targeted chemical cues, they demonstrate shifts in gene expression to re-accumulate lipids and transition back into functional adipocytes.

Furthermore, as multipotent adult stem cells, they maintain multilineage differentiation potential. Under appropriate environmental conditioning, they possess osteogenic differentiation and osteoblastic differentiation ability to form bone-like mineralized matrices, as well as chondrogenic differentiation capabilities. However, potency comparisons to ADSCs or BMSCs vary between individual studies and depend heavily on the specific donor, isolation method, and induction conditions. Beyond direct lineage conversion, their therapeutic mechanism operates primarily via potent paracrine signaling. Under stress or inflammatory stimulation, they adaptively alter their secretome, releasing a cocktail of growth factors and extracellular vesicle (EV) structures that modulate host immune responses, mitigate tissue fibrosis, and promote angiogenesis.

In regenerative medicine, molecular medicine, and tissue engineering, HMSC-DFAT function as a valuable human-background platform. Investigators deploy these primary cells in cell-based drug screening workflows to evaluate novel small molecules designed to regulate glucose uptake, manipulate lipid metabolism, or blunt chronic inflammatory cascades. In the field of tissue engineering and bone tissue engineering, their osteogenic potential is leveraged to develop biomaterial-embedded constructs aimed at bone regeneration. Researchers also utilize their high-yield secretome to explore acellular adipose therapeutic paradigms, characterizing the regulatory microRNA and protein cargos within each isolated extracellular vesicle.